Astragalus side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Astragalus. Common side effects include white blood cell count decreased among females and abdominal discomfort among males.
The phase IV clinical study is created by eHealthMe based on 303 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
303 people who take Astragalus and have side effects are studied.
What is Astragalus?
Astragalus has active ingredients of astragalus. eHealthMe is studying from 340 Astragalus users for its effectiveness, alternative drugs and more.
Number of Astragalus reports submitted per year:
Astragalus side effects by time on the drug *:
Astragalus side effects by gender *:
Astragalus side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Astragalus?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on astragalus (the active ingredients of Astragalus) and Astragalus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Astragalus:
- Astragalus (340 reports)
All Astragalus side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Melphalan Hydrochloride and Otitis - 2 seconds ago
- Edarbyclor and Urine Output - Decreased - 7 seconds ago
- Diphen and Otovel drug interaction - 10 seconds ago
- Hypogammaglobulinaemia and Confusion - 15 seconds ago
- Juvenile Chronic Myelomonocytic Leukaemia and Cough - 17 seconds ago